𝔖 Bobbio Scriptorium
✦   LIBER   ✦

γ-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells

✍ Scribed by G. V. Samant; P. W. Sylvester

Book ID
108677738
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
298 KB
Volume
39
Category
Article
ISSN
0960-7722

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Down-regulation of MEK/ERK signaling by
Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells
✍ Patrick Laprise; Marie-Josée Langlois; Marie-Josée Boucher; Christian Jobin; Nat 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

In vitro experiments have shown that the establishment of cell-cell contacts in intestinal epithelial cell cultures is a critical step in initiating ERK inhibition, cell cycle arrest, and induction of the differentiation process. Herein, we determined the mechanisms through which E-cadherin-mediated

TGF-β induces connexin43 gene expression
TGF-β induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways
✍ Charlotte Tacheau; Juliette Fontaine; Jennifer Loy; Alain Mauviel; Franck Verrec 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 1 views

## Abstract One of the shared physiological roles between TGF‐β and connexin family members is to inhibit epithelial cell cycle progression and consequently, to provide protection against malignant transformation. Herein, we demonstrated that TGF‐β1 induces the expression of connexin43 (Cx43) in no

CCR9 mediates PI3K/AKT-dependent antiapo
CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide
✍ Praveen K. Sharma; Rajesh Singh; Kristian R. Novakovic; John W. Eaton; William E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 723 KB

## Abstract Despite recent advances in treatment and management of prostate cancer (PCa), it remains the second leading cause of cancer‐related deaths among men in the US. Chemotherapy is one of the treatment alternatives for hormone refractory metastatic PCa. However, current chemotherapeutic regi